Novo Nordisk (NVO) EV/EBITDA US GAAP (year values)

2021 2021 2022 2022 2023   LTM ? CAGR 5 years ?
EV/EBITDA ? 4.14 3.94 4.02 3.76 4.08   0.14  
Changes by years, y/y, % +55% -5% +2% -6% +8%     +16.7%

Novo Nordisk. EV/EBITDA

Novo Nordisk. EV/EBITDA, changes, %

Novo Nordisk (NVO) EV/EBITDA US GAAP (quarter values)

2025Q1 2023Q2 2023Q3 2023Q4 2024Q1   LTM ?
EV/EBITDA ? 0.00 4.27 3.97 -0.03 0.14   0.14
Changes by years, y/y, % -4 410% -2 868% -101% -97%    
Changes by quarters, q/q, % -100% -7% -101% -612%    

Novo Nordisk. EV/EBITDA

Novo Nordisk. EV/EBITDA, changes, y/y, %

Novo Nordisk. EV/EBITDA, changes, q/q, %